Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly.

[1]  H J Cohen,et al.  The association of plasma IL-6 levels with functional disability in community-dwelling elderly. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  R. Kyle.  Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma. , 1997, Hematology/oncology clinics of North America.

[3]  J. Siemiatycki,et al.  Lymphoma, myeloma and occupation: Results of a case‐control study , 1996, International journal of cancer.

[4]  R. Casale,et al.  Risk of monoclonal gammopathy of undetermined significance: A case‐referent study , 1996, American journal of hematology.

[5]  T. Koepsell,et al.  Socioeconomic Status and the Incidence of Multiple Myeloma , 1996, Epidemiology.

[6]  M. Smulson,et al.  Deletion of genetic material from a poly(ADP-ribose) polymerase-like gene on chromosome 13 occurs frequently in patients with monoclonal gammopathies. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  R. Mckenna,et al.  Leukemias, myeloma, and other lymphoreticular neoplasms , 1995, Cancer.

[8]  G. Lyman,et al.  High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma. , 1994, Blood.

[9]  A. Tienhaara,et al.  Serum immunoreactive interleukin‐6 and C‐reactive protein levels in patients with multiple myeloma at diagnosis , 1994, British journal of haematology.

[10]  H. Cohen,et al.  Multiple myeloma in the elderly. , 1985, Journal of the American Geriatrics Society.

[11]  M. Passeri,et al.  Geriatric Assessment Technology , 1994 .

[12]  J. Kohout,et al.  Established populations for epidemiologic studies of the elderly: Study design and methodology , 1993, Aging.

[13]  J. Crawford,et al.  A Comparative Study of Monoclonal Gammopathies and Immunoglobulin Levels in Japanese and United States Elderly , 1993, Journal of the American Geriatrics Society.

[14]  R. Kyle.  Current concepts on monoclonal gammopathies. , 1992, Australian and New Zealand journal of medicine.

[15]  J J Gart,et al.  HLA and multiple myeloma among black and white men: evidence of a genetic association. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  G. I. Obrams,et al.  Epidemiology and Biology of Multiple Myeloma , 2012, Springer Berlin Heidelberg.

[17]  L. George,et al.  The association of age and depression among the elderly: an epidemiologic exploration. , 1991, Journal of gerontology.

[18]  J. Horm,et al.  Socioeconomic factors and cancer incidence among blacks and whites. , 1991, Journal of the National Cancer Institute.

[19]  G. Schechter,et al.  The Frequency of Monoclonal Gammopathy of Unknown Significance in Black and Caucasian Veterans in a Hospital Population , 1991 .

[20]  A. Dudley,et al.  Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting. , 1990, The Journal of laboratory and clinical medicine.

[21]  J. Schwartz.  Multinational Trends in Multiple Myeloma , 1990, Annals of the New York Academy of Sciences.

[22]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[23]  J. Corberand,et al.  Monoclonal gammopathies in human aging: Increased occurrence with age and correlation with health status , 1990, Mechanisms of Ageing and Development.

[24]  M. Jourdan,et al.  Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. , 1989, The Journal of clinical investigation.

[25]  J. Fraumeni,et al.  Multiple myeloma and occupation in Sweden. , 1988, Archives of environmental health.

[26]  S. Grufferman,et al.  Role of immune stimulation in the etiology of multiple myeloma: A case control study , 1987, American journal of hematology.

[27]  J. Crawford,et al.  Evaluation of monoclonal gammopathies in the "well" elderly. , 1987, The American journal of medicine.

[28]  U. Axelsson.  A 20-year follow-up study of 64 subjects with M-components. , 2009, Acta medica Scandinavica.

[29]  A. Smith,et al.  Case-control study of multiple myeloma and farming. , 1986, British Journal of Cancer.

[30]  H. Cohen,et al.  Multiple Myeloma in the Elderly , 1994, Clinics in geriatric medicine.

[31]  G. Fillenbaum,et al.  Screening the Elderly , 1985, Journal of the American Geriatrics Society.

[32]  E. DeLong,et al.  Socioeconomic status and risk of multiple myeloma. , 1985, Journal of epidemiology and community health.

[33]  J. Katzmann,et al.  The clinical aspects of biclonal gammopathies. Review of 57 cases. , 1981, The American journal of medicine.

[34]  R. Kyle,et al.  Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. , 1978, The American journal of medicine.

[35]  J. Radl,et al.  Immunoglobulin patterns in humans over 95 years of age. , 1975, Clinical and experimental immunology.

[36]  L. Elveback,et al.  Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. , 1972, Blood.

[37]  J. Fine,et al.  Frequency of Monoclonal Gammapathy (‘M Components’) in 13,400 Sera from Blood Donors , 1972, Vox sanguinis.

[38]  U. Axelsson,et al.  Frequency of pathological proteins (M-components) om 6,995 sera from an adult population. , 2009, Acta medica Scandinavica.